These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 18008256

  • 1. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis.
    Rosas-Taraco AG, Revol A, Salinas-Carmona MC, Rendon A, Caballero-Olin G, Arce-Mendoza AY.
    J Infect Dis; 2007 Dec 01; 196(11):1698-706. PubMed ID: 18008256
    [Abstract] [Full Text] [Related]

  • 2. Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis.
    Alavi-Naini R, Salimi S, Sharifi-Mood B, Davoodikia AA, Moody B, Naghavi A.
    Int J Tuberc Lung Dis; 2012 Oct 01; 16(10):1383-7. PubMed ID: 23107636
    [Abstract] [Full Text] [Related]

  • 3. Association between the -159C/T CD14 gene polymorphism and tuberculosis in a Korean population.
    Kang YA, Lee HW, Kim YW, Han SK, Shim YS, Yim JJ.
    FEMS Immunol Med Microbiol; 2009 Dec 01; 57(3):229-35. PubMed ID: 19758335
    [Abstract] [Full Text] [Related]

  • 4. CD14 gene promoter polymorphism in different clinical forms of tuberculosis.
    Pacheco E, Fonseca C, Montes C, Zabaleta J, García LF, Arias MA.
    FEMS Immunol Med Microbiol; 2004 Apr 09; 40(3):207-13. PubMed ID: 15039096
    [Abstract] [Full Text] [Related]

  • 5. CD14 -550 C/T, which is related to the serum level of soluble CD14, is associated with the development of respiratory syncytial virus bronchiolitis in the Japanese population.
    Inoue Y, Shimojo N, Suzuki Y, Campos Alberto EJ, Yamaide A, Suzuki S, Arima T, Matsuura T, Tomiita M, Aoyagi M, Hoshioka A, Honda A, Hata A, Kohno Y.
    J Infect Dis; 2007 Jun 01; 195(11):1618-24. PubMed ID: 17471431
    [Abstract] [Full Text] [Related]

  • 6. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both.
    Dezsofi A, Szebeni B, Hermann CS, Kapitány A, Veres G, Sipka S, Körner A, Madácsy L, Korponay-Szabó I, Rajczy K, Arató A.
    J Pediatr Gastroenterol Nutr; 2008 Sep 01; 47(3):283-7. PubMed ID: 18728522
    [Abstract] [Full Text] [Related]

  • 7. The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.
    Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, Marchant A, Sirugo G.
    Tuberculosis (Edinb); 2004 Sep 01; 84(6):347-52. PubMed ID: 15525557
    [Abstract] [Full Text] [Related]

  • 8. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.
    Morange PE, Tiret L, Saut N, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Cambien F, Juhan-Vague I, PRIME Study Group.
    Eur J Hum Genet; 2004 Dec 01; 12(12):1041-9. PubMed ID: 15367917
    [Abstract] [Full Text] [Related]

  • 9. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels.
    Heesen M, Blömeke B, Schlüter B, Heussen N, Rossaint R, Kunz D.
    Intensive Care Med; 2001 Nov 01; 27(11):1770-5. PubMed ID: 11810121
    [Abstract] [Full Text] [Related]

  • 10. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens.
    Schulz S, Zissler N, Altermann W, Klapproth J, Zimmermann U, Gläser C, Schaller HG, Reichert S.
    Int J Immunogenet; 2008 Dec 01; 35(6):457-64. PubMed ID: 19046305
    [Abstract] [Full Text] [Related]

  • 11. Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.
    Sivaram G, Tiwari SK, Bardia A, Anjum F, Vishnupriya S, Habeeb A, Khan AA.
    Hum Immunol; 2012 Feb 01; 73(2):201-5. PubMed ID: 22192785
    [Abstract] [Full Text] [Related]

  • 12. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T, Klein W, Epplen JT, Hebler U, Stachon A, May B.
    Hepatogastroenterology; 2005 Feb 01; 52(63):808-11. PubMed ID: 15966209
    [Abstract] [Full Text] [Related]

  • 13. Influence of CD14 polymorphism on CD14 expression in patients with extensive burns.
    Lin J, Yao YM, Dong N, Chai JK, Yu Y, Hou XX, Zhu JM, Sheng ZY.
    Burns; 2009 May 01; 35(3):365-71. PubMed ID: 18951711
    [Abstract] [Full Text] [Related]

  • 14. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population.
    Lichy C, Meiser H, Grond-Ginsbach C, Buggle F, Dörfer C, Grau A.
    J Neurol; 2002 Jul 01; 249(7):821-3. PubMed ID: 12140663
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children.
    Lachheb J, Dhifallah IB, Chelbi H, Hamzaoui K, Hamzaoui A.
    Tissue Antigens; 2008 May 01; 71(5):417-25. PubMed ID: 18312481
    [Abstract] [Full Text] [Related]

  • 16. CD14 expression in the first 24h of sepsis: effect of -260C>T CD14 SNP.
    de Aguiar BB, Girardi I, Paskulin DD, de Franca E, Dornelles C, Dias FS, Bonorino C, Alho CS.
    Immunol Invest; 2008 May 01; 37(8):752-69. PubMed ID: 18991094
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease.
    Vainas T, Stassen FR, Bruggeman CA, Welten RJ, van den Akker LH, Kitslaar PJ, Peña AS, Morré SA.
    J Vasc Surg; 2006 Aug 01; 44(2):326-32. PubMed ID: 16890863
    [Abstract] [Full Text] [Related]

  • 18. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease.
    Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, Oron A, Itskovich S, Ballin A, Houri S, Beigelman A, Lider O, Rechavi G, Amariglio N.
    J Infect Dis; 2004 Jun 01; 189(11):2057-63. PubMed ID: 15143473
    [Abstract] [Full Text] [Related]

  • 19. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.
    Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF.
    J Infect Dis; 2002 Nov 15; 186(10):1522-5. PubMed ID: 12404174
    [Abstract] [Full Text] [Related]

  • 20. CD14-159 C allele is associated with increased risk of mortality after burn injury.
    Barber RC, Aragaki CC, Chang LY, Purdue GF, Hunt JL, Arnoldo BD, Horton JW.
    Shock; 2007 Mar 15; 27(3):232-7. PubMed ID: 17304102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.